As the financing drought continues and their cash supplies dwindle, biotechs are resorting to big layoffs to drastically cut back on spending. (See Exhibit 1.)
Some of these layoffs look to be part of fairly systematic restructuring processes. For example, at BioTransplant Inc. ,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?